Heart Test Laboratories, Inc. (HSCS)
USD 2.88
(2.86%)
USD 2.88
(2.86%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 6.31 Million USD | 3.32% |
| 2023 | 6.11 Million USD | 29.67% |
| 2022 | 4.71 Million USD | 82.57% |
| 2021 | 2.58 Million USD | -32.66% |
| 2020 | 3.83 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 1.53 Million USD | -2.58% |
| 2024 Q4 | 1.87 Million USD | 22.72% |
| 2024 Q1 | 1.33 Million USD | -16.76% |
| 2024 Q2 | 1.57 Million USD | 18.16% |
| 2024 FY | 6.31 Million USD | 3.32% |
| 2023 Q4 | 1.59 Million USD | 21.99% |
| 2023 FY | 6.11 Million USD | 29.67% |
| 2023 Q3 | 1.31 Million USD | -26.17% |
| 2023 Q2 | 1.77 Million USD | 24.01% |
| 2023 Q1 | 1.43 Million USD | -27.74% |
| 2022 Q4 | 1.98 Million USD | 79.71% |
| 2022 FY | 4.71 Million USD | 82.57% |
| 2022 Q3 | 1.1 Million USD | 15.19% |
| 2022 Q2 | 956.85 Thousand USD | 41.51% |
| 2022 Q1 | 676.17 Thousand USD | -15.06% |
| 2021 FY | 2.58 Million USD | -32.66% |
| 2021 Q4 | 796.05 Thousand USD | 0.0% |
| 2020 FY | 3.83 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | 43.707% |
| Cerus Corporation | 143.15 Million USD | 95.586% |
| OrthoPediatrics Corp. | 137.01 Million USD | 95.389% |
| PetVivo Holdings, Inc. | 11.36 Million USD | 44.385% |
| Talis Biomedical Corporation | 67.18 Million USD | 90.596% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 74.672% |
| Inogen, Inc. | 236.08 Million USD | 97.324% |
| Spectral AI, Inc. | 20.86 Million USD | 69.717% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 88.717% |
| CVRx, Inc. | 76.14 Million USD | 91.702% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -79.09% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | 49.409% |
| Orthofix Medical Inc. | 667.42 Million USD | 99.053% |
| Venus Concept Inc. | 80.47 Million USD | 92.149% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 88.833% |
| Bioventus Inc. | 409.91 Million USD | 98.459% |
| BrainsWay Ltd. | 28.01 Million USD | 77.449% |
| Envoy Medical, Inc. | 17.89 Million USD | 64.698% |
| electroCore, Inc. | 32.03 Million USD | 80.274% |
| IceCure Medical Ltd | 16.87 Million USD | 62.561% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 85.11% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 64.168% |
| MaxCyte, Inc. | 84.84 Million USD | 92.553% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | 49.094% |
| Nexalin Technology, Inc. | 5.78 Million USD | -9.287% |
| PAVmed Inc | 64.82 Million USD | 90.254% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 87.63% |
| RxSight, Inc. | 103.85 Million USD | 93.916% |
| Sight Sciences, Inc. | 126.44 Million USD | 95.003% |
| SI-BONE, Inc. | 156.35 Million USD | 95.959% |
| TELA Bio, Inc. | 84.18 Million USD | 92.495% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 90.981% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 96.893% |
| LivaNova PLC | 843.54 Million USD | 99.251% |
| 908 Devices Inc. | 68.08 Million USD | 90.719% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 98.693% |
| Nemaura Medical Inc. | 7.13 Million USD | 11.494% |
| NeuroPace, Inc. | 75.29 Million USD | 91.609% |
| LENSAR, Inc. | 33.33 Million USD | 81.047% |
| Apyx Medical Corporation | 51.01 Million USD | 87.616% |
| Cutera, Inc. | 197.72 Million USD | 96.804% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 74.503% |
| BioSig Technologies, Inc. | 28.53 Million USD | 77.854% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 96.7% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 82.478% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 99.245% |
| Axonics, Inc. | 270.2 Million USD | 97.662% |
| Outset Medical, Inc. | 198.77 Million USD | 96.821% |
| IRIDEX Corporation | 31.81 Million USD | 80.14% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 96.494% |
| IRadimed Corporation | 30.12 Million USD | 79.025% |
| Tivic Health Systems, Inc. | 8.53 Million USD | 25.946% |
| INVO Bioscience, Inc. | 7.85 Million USD | 19.546% |
| Telesis Bio, Inc. | 63.48 Million USD | 90.048% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 93.582% |
| Varex Imaging Corporation | 224.8 Million USD | 97.189% |
| Quipt Home Medical Corp. | 148.66 Million USD | 95.75% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 46.103% |
| Pulmonx Corporation | 112.68 Million USD | 94.393% |
| Dynatronics Corporation | 9.9 Million USD | 36.231% |
| Modular Medical, Inc. | 17.52 Million USD | 63.955% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 68.701% |
| Semler Scientific, Inc. | 38.94 Million USD | 83.776% |
| InMode Ltd. | 215.68 Million USD | 97.071% |
| Bruker Corporation | 1.07 Billion USD | 99.413% |
| Cytosorbents Corporation | 48.33 Million USD | 86.929% |
| DexCom, Inc. | 1.69 Billion USD | 99.626% |
| Align Technology, Inc. | 2.07 Billion USD | 99.696% |
| Viveve Medical, Inc. | 22.17 Million USD | 71.505% |
| ZimVie Inc. | 275.12 Million USD | 97.703% |
| Movano Inc. | 29.69 Million USD | 78.719% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 95.397% |
| Nexalin Technology, Inc. | 5.78 Million USD | -9.287% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -79.09% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 98.949% |
| Profound Medical Corp. | 33.6 Million USD | 81.197% |
| Insulet Corporation | 939.9 Million USD | 99.328% |
| enVVeno Medical Corporation | 25.23 Million USD | 74.965% |
| Surmodics, Inc. | 98.69 Million USD | 93.598% |
| iCAD, Inc. | 22.22 Million USD | 71.571% |
| Nuwellis, Inc. | 22.61 Million USD | 72.059% |
| Biotricity, Inc. | 17.18 Million USD | 63.233% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 98.583% |
| Aethlon Medical, Inc. | 12.27 Million USD | 48.538% |
| InspireMD, Inc. | 22.95 Million USD | 72.469% |
| PAVmed Inc. | 64.82 Million USD | 90.254% |
| BIOLASE, Inc. | 34.66 Million USD | 81.771% |
| Beyond Air, Inc. | 61.7 Million USD | 89.76% |
| FONAR Corporation | 28.6 Million USD | 77.912% |
| AxoGen, Inc. | 149.33 Million USD | 95.769% |
| Vivani Medical, Inc. | 26.96 Million USD | 76.569% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 96.432% |
| Inari Medical, Inc. | 448.59 Million USD | 98.592% |
| UFP Technologies, Inc. | 58.08 Million USD | 89.123% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -28.222% |
| Tenon Medical, Inc. | 16.96 Million USD | 62.764% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | 14.537% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 85.674% |
| AdaptHealth Corp. | 1.07 Billion USD | 99.414% |
| Sintx Technologies, Inc. | 15.2 Million USD | 58.435% |
| NanoVibronix, Inc. | 4.97 Million USD | -27.052% |
| Quanterix Corporation | 118.1 Million USD | 94.65% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 46.103% |
| Sensus Healthcare, Inc. | 14.44 Million USD | 56.251% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 98.391% |
| TransMedics Group, Inc. | 182.82 Million USD | 96.544% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 77.487% |
| NeuroMetrix, Inc. | 11.09 Million USD | 43.073% |
| Hyperfine, Inc. | 52.87 Million USD | 88.05% |
| Establishment Labs Holdings Inc. | 172 Million USD | 96.327% |
| Biomerica, Inc. | 6.97 Million USD | 9.454% |
| Bone Biologics Corporation | 9.42 Million USD | 32.986% |
| AVITA Medical, Inc. | 80.77 Million USD | 92.178% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | 38.724% |
| Silk Road Medical, Inc | 186.35 Million USD | 96.61% |